The effect of lycopene treatment on ACE activity in rats with experimental diabetes

Journal of the Renin-angiotensin-aldosterone System : JRAAS
Serif OzmutluEbubekir Ceylan

Abstract

In this study, the anti-inflammatory and antioxidant known as lycopene was applied to rats with experimental diabetes with the aim of investigating the detection of diabetes-related complications, and to determine the possible role of lycopene in diabetes complications regarding the effects of ACE activity. In order to induce diabetes in rats in the diabetes (D) and diabetes+lycopene (DL) groups, rats were given 45 mg/kg single-dose streptozotocin (STZ) intraperitoneally (i.p.); lycopene (10 mg/kg/day dissolved in sunflower oil) was administered to the rats in the lycopene-only (L) and DL groups. Blood glucose levels and HbA1c% in diabetes+lycopene group and diabetes group increased (p <0.05) compared to control and only lycopene treated group. The highest level of ACE activity was observed in the (D) group (p < 0.05). Activity in the (L) group was also significantly greater than in the control group (p < 0.05). The (DL) group had lower (p < 0.05). ACE activity than the (D) group. Lycopene implementation was found to be effective in the inhibition of ACE activity, an important indicator of diabetes-related complications.

References

Apr 1, 1990·Journal of Clinical Chemistry and Clinical Biochemistry. Zeitschrift Für Klinische Chemie Und Klinische Biochemie·J W van Wersch, C Bank
May 1, 1993·The American Journal of the Medical Sciences·S S FemanR J Workman
Aug 1, 1997·Archives of Neurology·C S ConstantinescuJ A Cohen
Nov 24, 1999·European Journal of Gastroenterology & Hepatology·D KardumB Loncar
Feb 15, 2001·Circulation·M Burnier
Dec 12, 2003·The American Journal of Clinical Nutrition·Juergen G ErhardtChristiane Bode
Apr 13, 2006·JAMA : the Journal of the American Medical Association·Michael Brownlee, Irl B Hirsch
Jun 17, 2008·The British Journal of Nutrition·Laima BrazionisKerin O'Dea
Jan 17, 2009·Scandinavian Journal of Clinical and Laboratory Investigation·Mamdouh M Ali, Fatma G Agha
Mar 12, 2009·Current Protein & Peptide Science·Kwan Yi Chu, Po Sing Leung
Jan 26, 2010·European Journal of Ophthalmology·Zhen-Zuo LiLi Chen
Aug 7, 2010·Southern Medical Journal·Grant C Fowler, Deepa A Vasudevan
Jan 14, 2011·Diabetes Care·UNKNOWN American Diabetes Association
Jan 18, 2011·International Journal of Clinical Practice·A K SjølieF R R Hobbs

❮ Previous
Next ❯

Citations

Apr 30, 2014·Journal of Molecular Modeling·Ajit Kumar Prasad, Phool C Mishra
Jul 13, 2013·Journal of the Renin-angiotensin-aldosterone System : JRAAS·KeDa YangDeYun Feng
Sep 30, 2016·Journal of the Renin-angiotensin-aldosterone System : JRAAS·Nazish Iqbal KhanTabassum Mahboob

❮ Previous
Next ❯

Methods Mentioned

BETA
biosensors

Related Concepts

Related Feeds

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Cardiovascular Disorder in Diabetes

Diabetes is associated with an increased risk of cardiovascular disorders and heart failure. Discover the latest research here.